|
|
INFANT VACCINES PRODUCE AUTISM SYMPTOMS IN NEW PRIMATE STUDY BY UNIVERSITY OF PITTSBURGH SCIENTISTS
|
|
ROUTINE SAFETY STUDY THAT GOVERNMENT SCIENTISTS REFUSED TO DO ILLUSTRATES VACCINE PROGRAM AND MERCURY HEALTH RISKS
ATLANTA, GA -Findings released today showed
that infant monkeys given vaccines officially
recommended by the CDC and the American
Academy of Pediatrics (AAP) exhibited
autism-like symptoms. Lead investigator Laura
Hewitson of the University of Pittsburgh and
colleagues presented study results at the
International Meeting for Autism Research
(IMFAR) in London. Safety studies of
medicines are typically conducted in monkeys
prior to use in humans, yet such basic
research on the current childhood vaccination
regimen has never before been done.
The abstracts presented at IMFAR, the world's
top autism science conference, describe
biological changes and altered behavior in
vaccinated macaques that are similar to those
observed in children with autism.
Unvaccinated animals showed no such adverse
outcomes. The vaccines given were those
recommended for U.S. infants in the 1990s,
including several with the mercury
preservative thimerosal and the
Measles-Mumps-Rubella vaccine. Rates of
autism spectrum disorder among children born
in the 1990s surged dramatically, from about
1 in 5,000 to 1 in 150 children.
"This research underscores the critical need
for more investigation into immunizations,
mercury, and the alterations seen in autistic
children," stated Lyn Redwood, director of
SafeMinds. "SafeMinds calls for large scale,
unbiased studies that look at autism medical
conditions and the effects of vaccines given
as a regimen."
The group's request for research echoes that
of Dr. Bernadine Healy, Former NIH Director,
in a CBS interview earlier this week. She
asserted that public health officials have
been too quick to dismiss an autism-vaccine
connection when the research has been
insufficient. The government recently
conceded a federal vaccine court case which
agreed that a child regressed into autism as
a result of 9 vaccines given on one day.
"The full implications of this primate study
await publication of the research in a
scientific journal," noted Theresa Wrangham,
president of SafeMinds. "But we can say that
it demonstrates how the CDC evaded their
responsibility to investigate vaccine safety
questions. Vaccine safety oversight should be
removed from the CDC and given to an
independent agency."
|
|
SafeMinds Environmental Committee Applaudes Effort by Sierra Club to Reduce Mercury Emissions from Coal Plants
|
|
Since its inception, SafeMinds has advocated
for the removal of mercury from vaccines and
other medical products. Research sponsored
by SafeMinds -has increased the scientific
knowledge on the link between mercury and
neurological disorders and raise public
awareness of the dangers of mercury. The
direct injection of mercury-containing
vaccines into children has been shown to
readily accumulate mercury in the brain, and
the elimination of mercury from vaccines
continues to be a primary objective of SafeMinds.
In recent years, there has been extensive
evidence that the mercury levels in the USA
population has been increasing. Evidence
indicates that there are likelhy multiple
sources of this mercury including
mercury-containing vaccines, coal-burning
power plants, cement kilns, fluorescent light
bulbs, chlorine manufacturing plants, and
other sources. Since SafeMinds already has
committees which focus on mercury-containing
vaccines, a new SafeMinds Environmental
Committee was formed in December 2007 to
focus on mercury from environmental sources.
It is SafeMinds goal to end the tragedy of
mercury-induced neurological disorders.
Without lessening our focus on mercury
removal from vaccines, we plan to apply our
knowledge, energy, and skills into raising
awareness of environmental mercury and
advocate for the reduction and eventual
elimination of environmental sources of
mercury caused by human activity.
The SafeMinds Environmental Committee
applauds this effort by the Sierra Club to
reduce mercury emissions from coal plants:
The Sierra Club announced this week that it's
sending formal notices of intent to sue to
about 30 new coal plants across the country
in an effort to force them to better control
emissions of mercury and other toxic
pollutants. The states where the targeted
plants are located include Georgia, Kentucky,
Louisiana, North Carolina, South Carolina and
Texas.
"We want to give moms across the country some
peace of mind this Mother's Day," says Bruce
Nilles, director of the Sierra Club's
National Coal Campaign. "That's why we're
taking action today to ensure that these coal
plants make every effort to keep their toxic
mercury pollution out of our communities."
A recent study from the University of Texas
found that children's risk of developing
autism, a brain disorder that impairs
communication and social interaction,
increases with proximity to coal-fired power
plants. According to the researchers, a child
living 10 miles from a coal-burning power
plant has a 2 percent higher risk of
developing autism than a child living 20
miles away.
Coal-fired power plants are the single
largest man-made source of mercury pollution
in the United States. When the plants release
mercury into the air, it rains down into
lakes, rivers and streams and builds up in
the bodies of fish -- and the people who eat
the fish.
In February of this year, a federal appeals
court struck down the Bush administration's
mercury regulations for coal-fired power
plants, saying they failed to adequately
protect public health. The Sierra Club is
asking the coal plant developers to come up
with new plans to control mercury and other
toxic pollution before the facilities are built.
"There are affordable technologies widely
available today that can substantially reduce
mercury and other toxic pollution," says Pat
Gallagher, director of the Sierra Club's
Environmental Law Program. "In their rush to
build new coal plants, developers have turned
a blind eye to these technologies, and
correspondingly the health of children
everywhere."
For a map that shows all of the planned coal
plants in the United States and their current
status, click
here.
|
|
Former NIH Director Dr. Bernadine Healy Interviewed by CBS News
|
|
Says Question of Link Between Vaccines and Autism Still Open for Debate
In an exclusive interview, former NIH
Director Dr. Bernadine Healy tells CBS News'
Sharyl Attkisson that the question of a link
between vaccines and autism is still open for
debate.
CBS News correspondent Sharyl Attkisson wrote
this story for cbsnews.com:
Today, a second round of autism test cases
begins in federal vaccine court. Tonight on
the CBS Evening News, we'll have exclusive
interviews with the two families who are
bringing the cases: two of nearly 5,000
autism cases that have been filed in this
special court. The government and many
scientists have consistently maintained for
more than a decade that there is no link
between vaccines and autism. The Institute of
Medicine issued a report in 2004 that was
intended to put the controversy to rest,
saying that the weight of the body of
scientific evidence does not show a causal
link between vaccines and autism. However,
other scientists and parents disagree.
For our report, we interviewed Dr. Bernadine
Healy, the former head of the National
Institutes of Health and a member of the
Institute of Medicine who breaks with her
colleagues in this exclusive CBS News
interview: Dr. Healy says the government has
been too quick to dismiss the possibility of
a vaccine-autism link, and that it should be
explored with renewed vigor.
CBS News Video Link
http://www.cbsnews.com/stories/2008/05/12/cbsnews_investigates/main4086809.shtml
|
|
SafeMinds Board Member Dr. Vicky Debold Testifies Before
|
|
Interagency Autism Coordinating Committee's Strategic Plan for Autism Spectrum Disorders Research
Dr. Debold's testimony was as follows:
Good Afternoon. My name is Dr. Vicky Debold
and I represent SafeMinds, a private
charitable nonprofit organization founded to
investigate and raise awareness of the risks
to infants and children of exposure to
mercury from the environment and medical
products, including thimerosal in vaccines.
We appreciate the opportunity to provide
recommendations to the IACC on its strategic
plan for autism spectrum disorders research.
To that end, eight recommendations are
offered (more detailed rationale is provided
in our written testimony).
1. Acknowledge Autism As A National
Emergency and Epidemic.
With at least 1 out of every 150 children in
the United States affected, we respectfully
request that the NIH respond to autism as a
national emergency and appropriately allocate
the critical resources necessary to respond
to this pervasive epidemic before it affects
and even greater proportion of the nation's
children. Specific recognition of autism as
an epidemic is needed to both highlight the
preventable environmental cause and the
urgency of needed governmental action. To
that end, we recommend that NIH immediately
direct resources and launch calls for
proposals for environmental studies that will
find answers to specific urgent questions.
2. Allocate Sufficient Resources To Fund
Autism Research.
The IACC strategic plan must make a case that
sufficient funds need to be spent on autism
research, whether derived from Congress or as
part of the overall NIH funding allocation.
A sufficient funding level is justified due
to rapidly increasing direct and indirect
autism costs incurred by families, schools,
insurers and other payers.
3. Shift The Research Focus From Genetics
To The Environment.
Acknowledging the epidemic demands that the
research focus shift away from an exclusively
genetic model to one that investigates the
role of environmental factors combined with a
genetic vulnerability as a potential culprit
behind this otherwise unexplained epidemic.
The role of the environment has been widely
recognized as understudied and the absence of
a well-developed environmental research
agenda impedes the discovery of etiologic
factors and effective treatment strategies.
To that end, the IACC's strategic research
plan must include a special emphasis on
vaccines and their components as a possible
cause of autism. This topic is the only
specific research priority mentioned in the
Combating Autism Act legislative history. To
meet this requirement, the research plan
should include specific extramural funding
for a rigorous and prospectively conducted
and randomized trial that will establish
differences in health outcomes, including
autism spectrum disorders, among vaccinated
and unvaccinated children.
4. Develop A Leveraged Research Agenda.
The NIH should develop a leveraged research
agenda focused on prevention and treatment
that will benefit the greatest number of
lives and families as quickly as possible.
It should incorporate translational research
protocols that involve clinicians who care
for children with autism.
It should be understood that research on
cause and prevention does not disrespect
autistic persons or cultures any more than
does research to eliminate the causes of
deafness or blindness interfere with the
dignity and worth of these individuals and
cultures. Congress identified the strategic
plan goals for research and stipulated that
they be directed at cause, prevention, and
treatment. Those who seek answers related to
treatment and prevention are not the enemy of
those who are autistic.
5. Regard Autism As A Dynamic Disease
Process That Is Amenable To Treatment.
Currently, funded research perpetuates a
belief system that autism is fixed
pre-natally and immutable post-natally,
rather than as a condition that arises from
preventable pre- or post-natal exposures and
is amenable to treatment after birth.
Continuing to support this belief impedes
research initiatives to identifying effective
treatments. Typical treatment strategies are
targeted at ameliorating symptoms rather than
understanding the underlying biology and
pathologies responsible for symptom
manifestations. Such an approach does little
to reduce the morbidity associated with
autism.
6. Reclassify Autism As A Multi-Organ
Disease.
Numerous co-morbid disease states exist in
children with autism including abnormal
gastrointestinal function and inflammatory
bowel disease, evidence of increased
oxidative stress, severely disordered serum
chemistries, methylation disturbances,
increased body burdens of metals and
microglial activation in the brain. Research
must be initiated that identifies co-morbid
disease states because some biomedical
imbalances are amenable to medical and
nutritional interventions and may serve as
useful diagnostic and treatment
biomarkers.
7. Establish An NIH-Driven Research Agenda
That Is Not Driven By Researchers.
The current research agenda appears to be
driven by investigators seeking continuing
funding rather than by the NIH to achieve
specific research goals which, in turn, are
the basis for funding allocations.
Specifically, NIH should:
(a) include NIH goals as items to be scored
when reviewing grant proposals;
(b) announce NIH goals as program project
grants; and
(c) require Autism Centers of Excellence to
address NIH goals as part of their center
designation and to consider such project
proposals when scoring center proposals.
The strategic planning process must embrace a
re-engineered funding process to ensure that
the best and most focused science is
performed and accountability is increased and
should be performed by the Autism Advisory
Board, which has specific recognition in
legislative history.
8. Create A Formal Mechanism For Ongoing
Public-Private Research Agenda.
Throughout the draft matrix, reference is
made to a public/private partnership
regarding autism research activities. The
overall research budgets for private autism
research funders are equivalent to or surpass
that of our federal agencies. To enhance the
potential for improving knowledge, prevent
undue repetition in research activities and
fill in research gaps, a formal mechanism
needs to be established to coordinate and
benefit from collaborative public/private
efforts. Establishing strategic and specific
research agendas as well as funding decisions
must have direct consumer input on both
science and relevance, similar to the process
used by the Department of Defense to carry
out the Congressionally Directed Medical
Research Program on Autism.
|
|
SafeMinds 2008 Flu Vaccine Brochures Now Available
|
|
SafeMinds printed 2007-2008 flu vaccine brochures are now here. You can download the brochure here or e-mail eksafeminds@gmail.com to order printed copies.
|
|
Looking for an easy way to support SafeMinds?
|
|
Go Shopping!
That's right, go ahead and buy something for
yourself -- a new CD, the latest bestseller,
everyday essentials like pet food or
vitamins, even a computer. But first join
www.iGive.com/SafeMinds.
Every time you shop at one
of the over 680 name-brand stores in the
iGive.com Mall, we'll receive a donation of
up to 26% of each purchase you make, at no
cost to you.
Remember, donating to SafeMinds won't cost
you a thing. But we'll miss out on a lot of
extra dough, if you don't join. So visit
www.iGive.com/SafeMinds
now. Membership is
free and your privacy is guaranteed.
Click
here to join.
|
|
Visit The Age of Autism
|
|
|
The Age
of Autism is the nation's first daily Web
newspaper for the environmental-biomedical
community - those who believe autism is an
environmentally induced illness, that it is
treatable, and that children can recover. For
the most part, the major media in the United
States aren't interested in that point of
view, they won't investigate the causes and
possible biomedical treatments of autism
independently, and they don't listen to the
most important voices - those of the parents.
Visit the website at www.ageofautism.com.
|
|
|